Clopidogrel Resistance Is Associated With DNA Methylation of Genes From Whole Blood of Humans.
Ontology highlight
ABSTRACT: Antiplatelet therapy has become a cornerstone in the treatment of coronary heart disease (CHD). However, due to high-residual-platelet-reactivity, clopidogrel resistance (CR) is a common phenomenon, and it is rarely known about the relationship between CR and epigenetic changes. This study compared the whole genomic methylation patterns of blood samples from patients with CR (n = 6) and non-CR (n = 6) with the Human Methylation 850K BeadChip assay. We explored differentially methylated CpG sites, genes, and pathways using bioinformatics profiling. The CR and control groups showed significantly different DNA methylation at 7,098 sites, with 979 sites showing hypermethylation and 6,119 sites showing hypomethylation. The pyrosequencing method was used to validate four differenti
SUBMITTER: Yang J
PROVIDER: S-EPMC7844369 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA